This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Infosys' bid for Optimum Achieve Holdings cleared in Australia

( April 17, 2026, 02:35 GMT | Official Statement) -- MLex Summary: Infosys' has received a merger notification waiver for its proposed acquisition of Optimum Achieve Holdings. In a Friday statement, the Australian Competition and Consumer Commission said there is unlikely to be a substantial lessening of competition by the acquisition because there is a small horizontal overlap in the supply of IT implementation and support services for healthcare services in Australia. Additionally, Optimum Healthcare IT, a subsidiary of Optimum Achieve Holdings, has a small presence in Australia and there are alternative suppliers of IT implementation and support services for healthcare services in Australia, the regulator said. Infosys is a global consulting and IT services company registered in India. Optimum Achieve Holdings is based in the US. It specializes in providing services to the healthcare industry. Determination attached. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections